Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in TLymphoblastic Leukemia (T-ALL)

被引：1
|
作者：
Roy, Ntasha [1 ]
Mao, Zhengwei [2 ]
Xu, Chang [2 ]
Teachey, David T. [3 ]
Chen, Zhiguo [4 ]
Devidas, Meenakshi [5 ]
Chen, Xueyan [6 ]
Raetz, Elizabeth A. [7 ]
Loh, Mignon L. [8 ]
Hunger, Stephen P. [9 ]
Wood, Brent L. [1 ,10 ]
机构：
[1] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA
[2] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA
[4] Univ Florida, Biostatist, Gainesville, FL USA
[5] St Jude Childrens Res Hosp, Memphis, TN USA
[6] Fred Hutchinson Canc Ctr, Seattle, WA USA
[7] Dept Pediat, NYU Langone Hlth, New York, NY USA
[8] Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[9] Childrens Hosp Philadelphia, Philadelphia, PA USA
[10] Univ Washington, Dept Lab Med, Seattle, WA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT-GENERATION SEQUENCING AND REAL-TIME QUANTITATIVE PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM
    Ladetto, M.
    Brueggemann, M.
    Monitillo, L.
    Ferrero, S.
    Pepin, F.
    Drandi, D.
    Palumbo, A.
    Passera, R.
    Boccadoro, M.
    Carlton, V.
    Trautmann, H.
    Faham, M.
    Pott, C.
    HAEMATOLOGICA, 2013, 98 : 125 - 125
  • [32] Minimal Residual Disease (MRD) detection by next-generation sequencing and real-time quantitative PCR: A methodical comparison in ALL, MCL and MM
    Brueggemann, M.
    Ladetto, M.
    Monitillo, L.
    Ferrero, S.
    Pepin, F.
    Drandi, D.
    Palumbo, A.
    Boccadero, M.
    Carlton, V
    Trautmann, H.
    Kneba, M.
    Faham, M.
    Ritgen, M.
    Pott, C.
    ONKOLOGIE, 2013, 36 : 169 - 169
  • [33] INTERNATIONAL MULTI-LABORATORY NEXT-GENERATION SEQUENCING FOR MRD ANALYSIS IN ALL. A PILOT STUDY BY THE EUROCLONALITY-NGS CONSORTIUM
    Brueggermann, M.
    Knecht, H.
    Bartram, J.
    Bystry, V.
    Cazzaniga, G.
    Fazio, G.
    Ferrero, S.
    Fronkova, E.
    Garcia-Sanz, R.
    Grioni, A.
    Hancock, J.
    Jiminez, C.
    Kotrova, M.
    Ladetto, M.
    Moppett, J.
    Songia, S.
    Trka, J.
    Langerak, A. W.
    Darzentas, N.
    Herrmann, D.
    Pott, C.
    HAEMATOLOGICA, 2015, 100 : 31 - 31
  • [34] Next-Generation Sequencing-Based Measurable Residual Disease (MRD) Monitoring Is Highly Predictive for Outcome after Allogeneic Stem Cell Transplantation
    Thol, Felicitas
    Liebich, Alessandro
    Gabdoulline, Razif
    Klement, Piroska
    Schiller, Johannes
    Kandziora, Christian
    Flintrop, Madita
    Pankratz, Mira
    Wichmann, Martin
    Neziri, Blerina
    Klesse, Sabrina
    Chaturvedi, Anuhar
    Kloos, Arnold
    Gaidzik, Verena I.
    Paschka, Peter
    Bullinger, Lars
    Fiedler, Walter
    Heim, Albert
    Hambach, Lothar
    Stadler, Michael
    Hamwi, Iyas
    Eder, Matthias
    Krauter, Jurgen
    Schlenk, Richard F.
    Dohner, Konstanze
    Dohner, Hartmut
    Ganser, Arnold
    Heuser, Michael
    BLOOD, 2017, 130
  • [35] Post Transplantation Measurable Residual Disease (MRD) Monitoring Using Next-Generation Sequencing Is Highly Predictive for Relapseafter Allogeneic Stem Cell Transplantation
    Thol, Felicitas
    Heida, Bennet
    Buettner, Konstatin
    Wienecke, Clara
    Teich, Katrin
    Funke, Carolin
    Maximilian, Brandes
    Klement, Piroska
    Liebich, Alessandro
    Schiller, Johannes
    Wichmann, Martin
    Neziri, Blerina
    Chaturvedi, Anuhar
    Kloos, Arnold
    Gaidzik, Verena I.
    Paschka, Peter
    Bullinger, Lars
    Fiedler, Walter
    Heim, Albert
    Krauter, Jurgen
    Dohner, Konstanze
    Dohner, Hartmut
    Ganser, Arnold
    Stadler, Michael
    Hambach, Lothar
    Gabdoulline, Razif
    Heuser, Michael
    BLOOD, 2019, 134
  • [36] Next-generation sequencing for measuring minimal residual disease in AML
    Walter, Roland B.
    Appelbaum, Frederick R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 473 - 474
  • [37] Next-generation sequencing for measuring minimal residual disease in AML
    Roland B. Walter
    Frederick R. Appelbaum
    Nature Reviews Clinical Oncology, 2018, 15 : 473 - 474
  • [38] NEXT-GENERATION SEQUENCING (NGS) FOR BLOOD GROUP GENOTYPING
    Fichou, Y.
    Audrezet, M. P.
    Gueguen, P.
    Dupont, I
    Jamet, D.
    Le Marechal, C.
    Ferec, C.
    VOX SANGUINIS, 2013, 105 : 59 - 59
  • [39] Translation of next-generation sequencing (NGS) into molecular diagnostics
    Kotschote, Stefan
    Wagner, Carola
    Marschall, Christoph
    Mayer, Karin
    Hirv, Kaimo
    Kerick, Martin
    Timmermann, Bernd
    Klein, Harms-Georg
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 311 - 318
  • [40] IMPLEMENTATION OF NEXT-GENERATION SEQUENCING (NGS) FOR HLA GENOTYPING
    Christiansen, Mette
    Bonde, Lisbeth
    Walther, Tina
    Moller, Bjarne Kuno
    TISSUE ANTIGENS, 2015, 85 (05): : 373 - 373
12345